Compliance to cardiovascular treatment: clinicians and patients’ problem
Abstract
This literature review discusses various aspects of therapy compliance in cardiovascular patients. The clinician and patient-related causes of low compliance are analysed, and potential effectiveness of complex educational approach is emphasised. The results of major national and international studies (e.g., RELIPH Study) are presented.
About the Authors
G. V. Pogosova
State Research Centre for Preventive Medicine, Federal Agency on High Medical Technologies
Russian Federation
Russian Federation
Moscow
I. E. Koltunov
State Research Centre for Preventive Medicine, Federal Agency on High Medical Technologies
Russian Federation
Russian Federation
Moscow
G. Yu. Melik-Ogandzhanyan
N.I. Pirogov National Medico-Surgery Centre, Russian Federation Ministry of Health
Russian Federation
Russian Federation
Moscow
O. Yu. Sokolova
State Research Centre for Preventive Medicine, Federal Agency on High Medical Technologies
Russian Federation
Russian Federation
Moscow
References
1. McCormick D, Gurwitz JH, Lessard D, et al. Use of aspirin, beta-blockers, and lipid-lowering medication before recurrent acute myocardial infarction: missed opportunities for prevention? Arch Intern Med 1999; 6: 561-7.
2. Lewis WR, Peterson ED, Cannon CP, et al. An organized approach to improvement in guideline adherence for acute myocardial infarction. Results with the get with the guidelines quality improvement program. Arch Intern Med 2008; 168: 1813-9.
3. Kotseva K, Wood D, De Backer G, et al. EUROASPIRE III: A survey on the lifestyle, risk factors and use of cardioprotective drugtherapies in coronary patients from twenty-two European countries. Eur J Cardiovasc Prev Rehabil 2009; doi: 10.1097/HJR.0b013e3283294b1d
4. Steinberg BA, Bhatt DL, Mehta S, et al. Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease. Am Heart J 2008; 156(4): 719-27.
5. Sabate E. Adherence to long-term therapies: evidence for action. WHO, Geneva 2003.
6. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353(5): 487-97.
7. McGinnis B, Olson KL, Magid D, et al. Factors related to adherence to statin therapy. Ann Pharmacother 2007; 41(11): 1805-11.
8. Jokisalo E, Enlund H, Halonen P, et al. Factors related to poor control of blood pressure with antihypertensive drug therapy. Blood Press 2003; 12(1): 49-55.
9. Ragot S, Sosner P, Bouche G, et al. Appraisal of the knowledge of hypertensive patients and assessment of the role of the pharmacists in the management of hypertension: results of a regional survey. J Hum Hypertens 2005; 19(7): 577-84.
10. Svensson S, Kjellgren KI, Ahlner J, et al. Reasons for adherence with antihypertensive medication. Int J Cardiol 2000; 76(2-3): 157-63.
11. Werlemann BC, Offers E, Kolloch R. Herz. Compliance problems in therapy resistant Нypertension 2004; 29(3): 271-5.
12. Jokisalo E, Kumpusalo E, Enlund H, et al. Patients’ perceived problems with hypertension and attitudes towards medical treatment. J Hum Hypertens 2001; 15(11): 755-61.
13. Nunes MI. The relationship between quality of life and adherence to treatment. Curr Hypertens Rep 2001; 3(6): 462-5.
14. Kim MT, Han HR, Hill MN, et al. Depression, substance use, adherence behaviors, and blood pressure in urban hypertensive black men. Ann Behav Med 2003; 26(1): 24-31.
15. Perreault S, Lamarre D, Blais L, et al. Persistence with treatment in newly treated middle-aged patients with essential hypertension. Ann Pharmacother 2005; 39(9): 1401-8.
16. Van Wijk BL, Klungel OH, Heerdink ER, et al. Rate and deter¬minants of 10-year persistence with antihypertensive drugs. J Hypertens 2005; 23(11): 2101-7.
17. Yiannakopoulou ECh, Papadopulos JS, Cokkinos DV, et al. Adherence to antihypertensive treatment: a critical factor for blood pressure control. Eur J Cardiovasc Prev Rehabil 2005; 12(3): 243-9.
18. Rief W, Avorn J, Barsky AJ. Medication-attributed adverse effects in placebo groups: implications for assessment of adverse effects. Arch Intern Med 2006; 166(2): 155-60.
19. Schroeder K, Fahey T, Ebrahim S. Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. Cochrane Database Syst Rev 2004; 2: CD004804.
20. Taylor AA, Shoheiber O. Adherence to Antihypertensive Therapy With Fixed-Dose Amlodipine Besylate/Benazepril HCl Versus Comparable Component-Based Therapy. Congestive Heart Failure 2003; 9(6): 324-32
21. Ruzicka M, Leenen FH. Monotherapy versus combination therapy as first line treatment of uncomplicated arterial hypertension. Drugs 2001; 61(7): 943-54.
22. Chapman RH, Bernier JS, Petrilla AA, et al. Predictors of Adherence With Antihypertensive and Lipid-Lowering Therapy. Arch Intern Med 2005; 165: 1147-52.
23. Hyman DJ, Pavlik VN, Taylor WC, et al. Simultaneous vs sequential counseling for multiple behavior change. Arch Intern Med 2007; 167(11): 1152-8.
24. Allen LA, O’Donnell CJ, Giugliano RP, et al. Care concordant guidelines predicts decreased long-term mortality in patients with unstable angina pectoris and non-ST-elevation myocardial infarction. Am J Cardiol 2004; 93(10): 1218-22.
25. Elford RW, Yeo M. The impact of preventive cardiology on coronary artery disease. CMAJ 1988; 139(8): 719-24.
26. Wang L. Physician-related barriers to hypertension management. Med Princ Pract 2004; 13(5): 282-5.
27. Hobbs FD, Erhardt L. Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey. Fam Pract 2002; 19(6): 596-604.
28. Chabot I, Moisan J, Gregoire JP, et al. Pharmacist intervention program for control of hypertension. Ann Pharmacother 2003; 37(9): 1186-93.
29. Ferrier BM, Woodward CA, Cohen M, Williams AP Clinical practice guidelines. New-to-practice family physicians’ attitudes. Can Fam Physician 1996; 42: 463-8.
30. Davis DA, Taylor-Vaisey A. Translating guidelines into practice. A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guide¬lines. CMAJ 1997; 157(4): 408-16.
31. Кобалава Ж.Д., Котовская Ю.В., Склизкова Л.А. и др. Представления об артериальной гипертонии у пожилых и реальная клиническая практика в России (Результаты I этапа российской научно-практической программы АРГУС). Кардиология 2001; 11: 14-20.
32. Шапиро И.А., Калинина А.М. Профилактическая медицинская помощь больным артериальной гипертонией в амбула¬торно-поликлинических учреждениях Хабаровского края: состояние и перспективы. Кардиоваск тер профил 2002; 1: 16.
33. Еганян Р.А., Калинина А.М., Лахман Е.Ю. и др. Информированность и отношение к здоровью лиц с мягкой и умеренной артериальной гипертензией. Профил забол укреп здор 2006; 1: 12-8.
34. Оганов Р.Г., Погосова Г.В., Колтунов И.Е. и др. РЕЛИФ — Регулярное Лечение И профилактика — ключ к улучшению ситуации с сердечно-сосудистыми заболеваниями в России: результаты российского многоцентрового иссле-дования. Часть I. Кардиология 2007; 47(5): 58-66.
35. Оганов Р.Г., Погосова Г.В., Колтунов И.Е. и др. РЕЛИФ — Регулярное Лечение И профилактика — ключ к улучшению ситуации с сердечно-сосудистыми заболеваниями в России: результаты российского многоцентрового иссле-дования. Часть II. Кардиология 2007; 47(11): 30-9.
36. Оганов Р.Г., Погосова Г.В., Колтунов И.Е. и др. РЕЛИФ - Регулярное Лечение И профилактика — ключ к улучшению ситуации с сердечно-сосудистыми заболеваниями в России: результаты российского многоцентрового исследования. Часть III. Кардиология 2008; 48(4): 46-53.
Review
For citations:
Pogosova G.V., Koltunov I.E., Melik-Ogandzhanyan G.Yu., Sokolova O.Yu. Compliance to cardiovascular treatment: clinicians and patients’ problem. Cardiovascular Therapy and Prevention. 2009;8(4):98-102. (In Russ.)
Views:
993
Email this article 
